Author response for "Efficacy and safety of once‐weekly semaglutide vs once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes ( SUSTAIN China): a 30‐week double‐blind, phase 3a, randomised trial"
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
DW
hkk
Zilaap
aaaa
123
伯克利芙蓉王
Criminology34
123
吃葡萄不吐葡萄皮
高贵千琴
贪玩的秋柔
坚强冰枫
彭于彦祖
null
152455
OK
Nole
舒适的如萱
aajhajkahna
皖公网安备34019202002308
